AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Sola Security aims to be the Wix of cyber with $30 million Seed round
2
"Eventually, AI will surpass us in everything"—so what skills will still matter?
3
XTEND raises $20 million Series A for drone operating system
4
Cybereason secures $120 million investment amid leadership shakeup and abandoned merger
5
AI startup D-ID lays off a quarter of its workforce just days after Microsoft deal
More news

Sanofi

5 stories about Sanofi
מגזין מנהלים ריצ'רד פרנסיס מנכ"ל טבע

Teva’s stock surge comes to a halt, falling 14% amid weak 2025 outlook

30.01.25|Sophie Shulman
Despite a strong 80% gain in 2024, Teva’s stock dropped after the company revealed disappointing profitability and cash flow forecasts.
ריצרד פרנסיס נשיא ו מנכל חברה חברת טב

Teva’s 10-year turnaround takes shape with stunning trial results

18.12.24|Sophie Shulman
Duvakitug signals a brighter future for the Israeli pharma giant. 
מפגש עיתונאים ראשון עם נשיא ומנכל חברת טבע ריצ'רד פרנסיס

Teva shares jump as its most promising drug shows exceptional trial results

17.12.24|Sophie Shulman
Duvakitug, designed to treat colitis and Crohn’s disease, exceeded expectations and positions Teva to compete in the $28 billion global market for inflammatory bowel disease treatments.
מייסדי Nucleai

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach
The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
עומרי שור מנכ"ל מדיסייף

Medisafe raises $30 million in Series C led by pharma giant Sanofi

25.02.21|Meir Orbach
The company expanded its platform in 2020 with the launch of Medisafe Care Connector, which digitally connects patients and doctors